Lexx

Saturday, 14 September 2024

Latest News for: lexx

Edit

Tinygemsbreaks Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyeing Market Potential With Unique Delivery Platform, GLP-1 Program

MENA FN 14 Sep 2024

(MENAFN - Investor Brand Network). Lexaria Bioscience Corp. (NASDAQ. LEXX) recently released its fiscal report for the third quarter of the 2024 financial year (–Q3, 2024–).–Of note was growth in ... .

Edit

Cannabisnewsbreaks Lexaria Bioscience Corp. (NASDAQ: LEXX) Shares Letter From Outgoing CEO

MENA FN 06 Sep 2024

(MENAFN - Investor Brand Network). Lexaria Bioscience (NASDAQ. LEXX, LEXXW) , a global innovator in drug delivery platforms, provided a strategic letter from outgoing CEO Chris Bunka updating all ... .

Edit

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Shares Letter from Outgoing CEO

Invezz 06 Sep 2024

LEXX, LEXXW), a global innovator in drug delivery platforms, provided a strategic letter from outgoing CEO Chris Bunka updating all stakeholders ... The latest news and updates relating to LEXX are ...

Edit

Tinygemsbreaks Lexaria Bioscience Corp. (NASDAQ: LEXX) Appoints Medical Device And Pharmaceutical Industries Veteran As New CEO

MENA FN 05 Sep 2024

(MENAFN - Investor Brand Network). Lexaria Bioscience (NASDAQ. LEXX, LEXXW) , a global innovator in drug delivery platforms, today announced the appointment of Richard Christopher as the new CEO, ... .

Edit

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Appoints Medical Device and Pharmaceutical Industries Veteran as ...

Invezz 05 Sep 2024

LEXX, LEXXW), a global innovator in drug delivery platforms, today announced the appointment of Richard Christopher as the new CEO, effective August 31, 2024 ... company’s newsroom at https.//ibn.fm/LEXX.

Edit

Tinygemsbreaks Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Material Transfer Agreement To Evaluate Dehydratech(TM) Technology In ...

MENA FN 03 Sep 2024

(MENAFN - Investor Brand Network). Lexaria Bioscience (NASDAQ. LEXX, LEXXW) , a global innovator in drug delivery platforms, has entered into a Materials Transfer Agreement with a pharmaceutical ... .

Edit

TinyGemsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Material Transfer Agreement to Evaluate DehydraTECH(TM) Technology ...

Invezz 03 Sep 2024

LEXX, LEXXW), a global innovator in drug delivery platforms, has entered into a Materials Transfer Agreement with a pharmaceutical company ... The latest news and updates relating to LEXX are available in the company’s newsroom at https.//ibn.fm/LEXX.

Edit

Lexaria Bioscience Corp. (NASDAQ: LEXX) Grows Global Patent Portfolio To 41 Maintains Focus On GLP-1 ...

MENA FN 30 Aug 2024

(MENAFN - Investor Brand Network). Lexaria, a global innovator in drug delivery platforms, has added three new patents to its portfolio, bringing the total to 41 Two patents were awarded ... .

Edit

Hempnewsbreaks Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Additional Tolerability, PK Test Results

MENA FN 29 Aug 2024

(MENAFN - Investor Brand Network). Lexaria Bioscience (NASDAQ. LEXX, LEXXW) , a global innovator in drug-delivery platforms, is reporting that the tolerability and additional pharmacokinetic (–PK–) ... .

Edit

Cannabisnewsbreaks Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces First Results From Second GLP-1 Human Pilot Study ...

MENA FN 28 Aug 2024

(MENAFN - Investor Brand Network). Lexaria Bioscience (NASDAQ. LEXX, LEXXW) , a global innovator in drug delivery platforms, is announcing receipt of the first results from human pilot study #2, ... .

Edit

Lexaria Bioscience Corp. (NASDAQ: LEXX) Validates Technology's Superiority, Moving Closer To A Share In The ...

MENA FN 27 Aug 2024

(MENAFN - Investor Brand Network). Lexaria, a global innovator in drug delivery platforms, just reported positive results from its applied research program conducted in collaboration with the ... .

Edit

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces First Results from Second GLP-1 Human Pilot ...

Invezz 27 Aug 2024

LEXX, LEXXW), a global innovator in drug delivery platforms, is announcing receipt of the first results from human pilot study #2, GLP-1-H24-2 ... The latest news and updates relating to LEXX are ...

Edit

Lexaria Bioscience Corp. (NASDAQ: LEXX) To File Its IND Application With The FDA For Its ...

MENA FN 23 Aug 2024

(MENAFN - Investor Brand Network). Lexaria, a global innovator in drug delivery platforms, expects to submit its IND application for its planned U.S. Phase 1b Hypertension Clinical Trial with ... .

Edit

Cannabisnewsbreaks Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports Positive 8-Week Body Weight Results From Ongoing Diabetes ...

MENA FN 22 Aug 2024

(MENAFN - Investor Brand Network). Lexaria Bioscience (NASDAQ. LEXX, LEXXW) , a global innovator in drug delivery platforms, is reporting on 8-week body weight results from its ongoing animal study ... .

Edit

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports Positive 8-Week Body Weight Results from Ongoing ...

Invezz 22 Aug 2024

LEXX, LEXXW), a global innovator in drug delivery platforms, is reporting on 8-week body weight results from its ongoing animal study WEIGHT-A24-1 ... The latest news and updates relating to LEXX are ...